Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with Massdevice +3.
3. Abiomed gets a little relief from The Street
Shares of Abiomed Inc. (NSDQ:ABMD, which were white-hot for the first six months of 2011 before a precipitous selloff, may have some room to grow again, according to analysts on Wall Street.
2. Bayer confirms international recall of diabetes test strips
Bayer HealthCare’s voluntary U.S. recall of a series of diabetes glucose monitor test strips gets more severe treatment overseas with a government directed recall of affected and related strips in Hong Kong.
1. Medtronic’s former CEO Bill Hawkins one-on-one
In the first installment of an in-depth interview with Medtronic Inc.’s (NYSE:MDT) former CEO Bill Hawkins, he tells us that the company gave him a sword and he handed back the world.